AI Article Synopsis
- Primary laryngeal lymphoma is a rare type of cancer, making up less than 1% of laryngeal cancers and its treatment varies based on the disease's stage and severity.
- A case study describes a 64-year-old woman with dysphagia (difficulty swallowing) and a feeling of something stuck in her throat, which led to the discovery of a tumor diagnosed as diffuse large B-cell lymphoma after laryngoscopy and biopsies.
- The patient underwent chemotherapy followed by radiotherapy and showed significant improvement after 2 years, highlighting the need for tailored diagnostic and treatment strategies due to the rarity and diverse symptoms of this cancer.
Article Abstract
Primary laryngeal lymphoma is rare, accounting for less than 1% of all laryngeal cancers. Treatment depends on the stage and severity of the disease. We here report the exceptional case of a 64-year-old woman, non-smoker, suffering from dysphagia for solids and a foreign body sensation. Laryngoscopy and biopsies revealed polyploid tumor of the left epiglottic fold. The diagnosis of diffuse large B-cell lymphoma was made. The patient underwent chemotherapy followed by radiotherapy, with significant improvement at 2-year follow-up, with no local recurrence. Due to the rarity of this disease and the variety of symptoms, the optimal management strategy for this type of cancer is controversial, requiring a specific diagnostic and therapeutic approach.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11260049 | PMC |
| http://dx.doi.org/10.11604/pamj.2024.47.161.41032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Elucidating the molecular and immune interplay between head and neck squamous cell carcinoma and diffuse large B-cell lymphoma through bioinformatics and machine learning.
Transl Cancer Res
November 2024
School of Life Sciences, Jiangsu University, Zhenjiang, China.
Background: Head and neck squamous cell carcinoma (HNSCC) contributes significantly to global health challenges, presenting primarily in the oral cavity, pharynx, nasopharynx, and larynx. HNSCC has a high propensity for lymphatic metastasis. Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, exhibits significant heterogeneity and aggressive behavior, leading to high mortality rates.
View Article and Find Full Text PDFPrimary Laryngeal Lymphoma: A Case Report of a Rare Entity.
Cureus
October 2024
Otorhinolaryngology, Saveetha institute of medical and technical sciences, Chennai, IND.
Article Synopsis
- * A case study of a 53-year-old male with symptoms like weight loss, hoarseness, and dysphagia led to the diagnosis of diffuse large B-cell lymphoma (DLBCL) through a biopsy, following imaging that revealed a significant lesion in the larynx.
- * The patient successfully underwent eight cycles of CHOP chemotherapy, resulting in complete remission with no recurrence in two years, highlighting the need for early detection and treatment due to symptom similarities with other laryngeal issues.
MiR-525-5p modulates cell proliferation, cell cycle, and apoptosis in Burkitt's lymphoma by targeting MyD88 and regulating the NF-κB signaling pathway.
Ann Hematol
November 2024
Department of Hematology, The First Affiliated Hospital of Dali University, Dali, Yunnan, 671000, P.R. China.
MiR-525-5p functions as an oncomiRNA or tumor suppressor, and has been reported in various cancer types, including laryngeal squamous cell carcinoma, glioma, breast cancer, and cervical cancer. However, the biological functions and precise mechanisms of miR-525-5p remain unclarified in Burkitt's lymphoma (BL). This study aimed to explore the roles of miR-525-5p in BL, with the goal of ascertaining its regulatory effects on the nuclear factor-kappaB (NF-κB) signaling pathway by targeting Myeloid differentiation factor 88 (MyD88).
View Article and Find Full Text PDFCancer Incidence among Marines and Navy Personnel and Civilian Workers Exposed to Industrial Solvents in Drinking Water at US Marine Corps Base Camp Lejeune: A Cohort Study.
Environ Health Perspect
October 2024
National Center for Environmental Health, Agency for Toxic Substances and Disease Registry, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Drinking water at US Marine Corps Base Camp Lejeune, North Carolina, was contaminated with trichloroethylene and other industrial solvents from 1953 to 1985.
Methods: A cohort cancer incidence study was conducted of Marines/Navy personnel who began service and were stationed at Camp Lejeune () or Camp Pendleton, California () between 1975 and 1985 and civilian workers employed at Camp Lejeune () or Camp Pendleton () between October 1972 and December 1985. Camp Pendleton's drinking water was not contaminated with industrial solvents.
Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature.
Int J Pediatr Otorhinolaryngol
November 2024
Louisiana State University Health Sciences Center, Department of Otolaryngology-Head and Neck Surgery, New Orleans, LA, USA; Children's Hospital of New Orleans, Division of Otolaryngology, New Orleans, LA, USA. Electronic address:
Article Synopsis
- Head and neck squamous cell carcinoma (HNSCC) is rare in pediatric patients compared to adults, where other tumors like lymphomas are more common; the disease's association with the human papillomavirus raises concerns about its prevalence and impact on children's health.
- This study examined data from the National Cancer Institute’s SEER database to analyze the incidence, characteristics, treatments, and survival rates of pediatric HNSCC cases from 1973 to 2019, identifying 292 cases primarily affecting males and older children.
- Results showed that nasopharynx is the most common site for HNSCC in children, with a notable overall 5-year survival rate of 83.6%, and the disease tends to be more
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!